You just read:

Surveyed MCO Pharmacy and Medical Directors Report that the Market-Leading TNF-Alpha Inhibitors Enbrel and Humira Continue to Enjoy the Most Favorable Formulary Coverage in the United States

News provided by

Decision Resources Group

Sep 19, 2016, 08:30 ET